Consequently, dominant negative mutants of PAX5 and IKZF1 found in the majority of B-ALL lesions alleviate glucose and energy restrictions, which foster malignant transformation [68]. This evidence concerns the gene PAX5 and precursor B-cell acute lymphoblastic leukemia.